MedFirst Healthcare Services (4175) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 杏一

MedFirst Healthcare Services (4175) reported revenue of NT$697.7 million for Oct 2026, +3.3% year on year and +5.3% from the previous month. Revenue for Jan–Oct 2026 was NT$6.68 billion (+1.5% year on year).

Year-on-year revenue growth: 5 months in a row. →

In Oct 2026, it ranked No. 12 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$642 million24/10Nov 2024 NT$605.4 millionDec 2024 NT$802.7 millionJan 2025 NT$629.9 millionFeb 2025 NT$589.7 million25/02Mar 2025 NT$683.8 millionApr 2025 NT$622.2 millionMay 2025 NT$690.3 millionJun 2025 NT$698.1 million25/06Jul 2025 NT$655.8 millionAug 2025 NT$668.3 millionSep 2025 NT$660.6 millionOct 2025 NT$675.5 million25/10Nov 2025 NT$621.6 millionDec 2025 NT$817.3 millionJan 2026 NT$644.5 millionFeb 2026 NT$560.7 million26/02Mar 2026 NT$682.1 millionApr 2026 NT$644.4 millionMay 2026 NT$656.2 millionJun 2026 NT$775 million26/06Jul 2026 NT$659 millionAug 2026 NT$693 millionSep 2026 NT$662.6 millionOct 2026 NT$697.7 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$697.7 million+3.3%+5.3%
Sep 2026NT$662.6 million+0.3%-4.4%
Aug 2026NT$693 million+3.7%+5.2%
Jul 2026NT$659 million+0.5%-15.0%
Jun 2026NT$775 million+11.0%+18.1%
May 2026NT$656.2 million-4.9%+1.8%
Apr 2026NT$644.4 million+3.6%-5.5%
Mar 2026NT$682.1 million-0.2%+21.6%
Feb 2026NT$560.7 million-4.9%-13.0%
Jan 2026NT$644.5 million+2.3%-21.1%
Dec 2025NT$817.3 million+1.8%+31.5%
Nov 2025NT$621.6 million+2.7%-8.0%
Oct 2025NT$675.5 million+5.2%+2.3%
Sep 2025NT$660.6 million+1.7%-1.1%
Aug 2025NT$668.3 million+3.0%+1.9%
Jul 2025NT$655.8 million+5.4%-6.1%
Jun 2025NT$698.1 million-2.3%+1.1%
May 2025NT$690.3 million+9.5%+11.0%
Apr 2025NT$622.2 million+4.6%-9.0%
Mar 2025NT$683.8 million+6.5%+16.0%
Feb 2025NT$589.7 million+5.8%-6.4%
Jan 2025NT$629.9 million-1.1%-21.5%
Dec 2024NT$802.7 million+8.4%+32.6%
Nov 2024NT$605.4 million-2.0%-5.7%
Oct 2024NT$642 million-0.1%-1.2%

Jan–Oct 2026 cumulative: NT$6.68 billion (+1.5% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: MedFirst Healthcare Services vs PEC / MedFirst Healthcare Services vs Lotus Pharm / MedFirst Healthcare Services vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16